"Courtesy" Letter Process Under Review At FDA

FDA plans to revisit its use of "courtesy" letters to respond to inappropriate dietary supplement claims, Center for Food Safety & Applied Nutrition's Robert Moore, PhD, said at a joint CRN/CHPA briefing in Washington, D.C. Feb. 16.